Sanofi SA (SNY)

53.21 +0.76  +1.45% NASDAQ Aug 3, 16:59 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/05/2021 09:00 EST Misc Sanofi SA Fourth Quarter Earnings Conference Call for 2020
02/05/2021 Earnings Sanofi SA Fourth Quarter Earnings for 2020 Release
10/29/2020 Earnings Sanofi SA Third Quarter Earnings Result for 2020
10/29/2020 Misc Sanofi SA Third Quarter Earnings Conference Call for 2020
07/29/2020 Earnings Sanofi SA Second Quarter Earnings Result for 2020
07/29/2020 Misc Sanofi SA Second Quarter Earnings Conference Call for 2020
04/30/2020 Dividends Amount: 1.699, Declared Date: Mar 05 2020, Pay Date: May 26 2020
04/28/2020 Misc Sanofi SA Annual General Meeting in 2019
04/24/2020 Earnings Sanofi SA First Quarter Earnings Result for 2020
04/24/2020 Misc Sanofi SA First Quarter Earnings Conference Call for 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.sanofi.com
  • Investor Relations URL: http://en.sanofi.com/investors/investors.aspx
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Oct. 29, 2020
  • Last Earnings Release: Jul. 29, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Apr. 30, 2020
  • Description: Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Lantus, representing just under 10% of total sales. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Top Fund Holders

Symbol Name Weighting
FPHAX Fidelity® Select Pharmaceuticals Port 9.09%
HHL.TO Harvest Healthcare Leaders Inc ETF 5.14%
PPH VanEck Vectors Pharmaceutical ETF 5.07%
FTQGX Fidelity® Focused Stock 2.55%
ACSYX Invesco Comstock C 2.19%
DODGX Dodge & Cox Stock 2.10%
CII BlackRock Enhanced Cap & Inc 1.79%
JTD Nuveen Tax-Adv Div Growth 1.65%
DODBX Dodge & Cox Balanced 1.48%
IBB iShares Nasdaq Biotechnology ETF 1.23%
FPUKX Fidelity® Puritan® K 0.91%
HQH Tekla Healthcare Investors 0.74%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.